A new visualisation tool is shedding light on breast cancer spread. This fluorescent probe, called Illusia, allows dynamic ...

Cell-free DNA-based liquid biopsies showed promise for monitoring response to pancreatic cancer therapies and making ...

The DESTINY-Breast09 study, reported at ASCO, compared antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) and ...

Prostate cancer remains the most common cancer in men and the second deadliest. The median age of diagnosis is 67. Yet, ...

CHICAGO -- For the first time in a phase III trial, overall survival (OS) in unresectable pancreatic cancer improved ...

On Monday, BriaCell Therapeutics Corp. (NASDAQ: BCTX) announced robust overall survival and clinical benefit data from its ...

Elder Spencer Blanchard of Salem, Oregon, is serving a mission while battling neuroblastoma. "I can’t change that I have ...

Daniel J. Stone Former President Joe Biden’s metastatic cancer diagnosis brings together two controversial issues: PSA testing for prostate cancer and presidential politics.  To understand what is at ...

Radium-223 in mCRPC showed long-term favorable safety, low second primary malignancies/fracture rates, and consistent overall ...

Dirk Arnold, MD, PhD, medical director, Asklepios Tumour Biology Centre, discusses a phase 3 clinical trial investigating amivantamab in metastatic colorectal cancer.

EBC-129 demonstrates early activity and manageable safety in patients with heavily pretreated pancreatic cancer, supporting ...

Anlotinib plus chemotherapy demonstrated similar efficacy as bevacizumab plus chemotherapy for certain patients with ...